CMG Pharmaceuticals (058820), led by CEO Lee Joo-hyung, announced on the 10th that its family-oriented health functional food brand CMG Health Research Institute has been rebranded as ‘Cha Biotech Health’, with the launch of its first product, ‘PDRN Active’.This rebranding effort by CMG Pharmaceuticals aims to intuitively convey the company’s bio-based identity, a core asset of the Cha Biotech Group, directly to consumers.

The new ‘Cha Biotech Health’ will position itself under the slogan, “Slowing Down Time, Extending Healthy Life,” aiming to become a go-to brand for slow aging care.

The initiative indicates a strategic pivot towards offering products that cater to both health and beauty-conscious consumers.The debut product ‘PDRN Active’ features 100mg of salmon-derived extract per film, which contains 86% PDRN.

The formulation is enriched with low-molecular fish collagen, elastin peptides, hyaluronic acid, centella extract, and vitamin C, specifically targeting consumers interested in skin elasticity and inner beauty management.The delivery system utilizes an orally disintegrating film (ODF), allowing for convenient consumption without water, thus enhancing both ease-of-use and absorption rates.

CMG Pharmaceuticals has become a pioneer in securing FDA approval for ODF formulations in South Korea, underscoring its technological prowess in this segment.CEO Lee Joo-hyung emphasized the introduction of ‘PDRN Active’ as the starting point for a differentiated health and beauty product lineup under the Cha Biotech Health banner, aiming to continually enhance consumer health and beauty.This strategic rebranding and product launch signal an important shift in CMG Pharmaceuticals’ business model, emphasizing innovation in health and beauty intersections.

The introduction of ODF technology not only enhances consumer engagement but positions the brand competitively in a fast-evolving beauty sector.For the industry at large, this move reflects an increasing trend towards integrating health and beauty solutions, signaling a substantial opportunity for distribution partners to capitalize on consumer demand for multifunctional products.